On June 28, 2019, the FDA approved another biosimilar for bevacizumab (Avastin), called Zirabev (bevacizumab-bvxr) for five different cancer types including: Metastatic colorectal cancer Unresectable, locally advanced, recurrent, or metastatic non squamous non-small cell lung cancer (NSCLC) Recurrent glioblastoma Metastatic renal cell carcinoma, and Persistent,…
Read Full Post
Angela Nicholas, M.D., caregiver, and wife to the late John MacLeod who was a Fight CRC advocate describes how to use the Fight CRC Late Stage MSS CRC clinical trial finder, and what a patient can expect once they enter a clinical trial. She also…
Read Full Post
UPDATE: In May 2019, the Final Research Plan for Colorectal Cancer: Screening was made available to the public on the USPSTF website. Why is this a big deal? The results could lead to a guideline update, for example, moving the age of screening for average-risk…
Read Full Post
Fight Colorectal Cancer (Fight CRC) was busy at this year’s conference meeting with leaders in the oncology field, engaging with research advocates, and convening the 7th meeting of the Fight CRC Immunotherapy (IO) Workgroup. Our team tracked the latest developments in research to share those…
Read Full Post
Fight CRC is excited to announce our new Board Members. Eric Hausmann Eric became involved with Fight Colorectal Cancer (Fight CRC) as an advocate after his late wife Rose Hausman. Rose was healthy, with no family history of the disease when in 2005, at age…
Read Full Post
It’s difficult to avoid the news of how opioids have ravaged many cities in the United States. And rightly so. According to the National Institute on Drug Abuse, more than 130 people die every day from an opioid overdose. While the midwest has been known…
Read Full Post
Recently, Fight CRC attended the 2019 Digestive Disease Week Conference in San Diego, Calif. along with over 14,000 researchers, clinicians, and patient advocates. In addition to attending research sessions and raising awareness about Fight CRC’s patient resources, our team continued the momentum from the first…
Read Full Post
Everyone experiences exhaustion at some point or another. However, the type of tiredness experienced by someone without cancer is incredibly different than the type of tiredness experienced by a cancer survivor. In fact, saying “I’m tired” could even be an understatement. We touched base with…
Read Full Post
Join the GI CONNECT Interactive Masterclass on Colorectal Cancer Management: Expert Insights Into The Latest Clinical Data and Their Application Into Clinical Practice GI CONNECT is of a group of international experts in gastrointestinal (GI) oncology who develop educational programs to support medical oncologists around…
Read Full Post
Climb for a Cure 2019 is upon us and for the fourth year in a row, Fight CRC will be summiting a beautiful Colorado peak in the prime hiking month of July! Our aim is to raise more research dollars while also deepening the bonds…
Read Full Post